Mayo Clinic

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).

2,844 total trials 544 currently recruiting 1816 completed early-phase tilt top decile by trial count

Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.

Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.

Top-decile sponsor footprint

Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,844 total, page 56 of 57

COMPLETED Phase 1

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

NCT00987376

COMPLETED

The Relationship Between the Response to Mental Stress and Vascular Endothelial Function

NCT00975559

COMPLETED

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

NCT00897923

COMPLETED NA

Emergency Department Telephone Quitline

NCT00394420

COMPLETED Phase 3

Bupropion SR for Treating Smokeless Tobacco Use

NCT00414180

COMPLETED

Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration

NCT00587535

COMPLETED NA

Molecular Breast Imaging in Women With Atypia and LCIS

NCT00620087

COMPLETED Phase 1

Stage IV Colorectal CA ALIMTA

NCT00166465

COMPLETED NA

A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty

NCT00589147

COMPLETED Phase 3

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

NCT00432458

COMPLETED Phase 3

Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease

NCT00170027

COMPLETED Phase 2

Cervical Mobilization vs. Standard Physical Therapy for Chronic Neck Pain

NCT01092715

COMPLETED Phase 1

The Effects of HIV Protease Inhibitors in Severe Sepsis

NCT00346580

COMPLETED Phase 1

Nutritional Restriction and Activity Thermogenesis

NCT00065338

COMPLETED Phase 3

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

NCT00035815

COMPLETED Phase 2

Moexipril for Primary Biliary Cirrhosis

NCT00588302

TERMINATED Phase 2

Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis

NCT00217022

COMPLETED Phase 3

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

NCT00046904

TERMINATED NA

Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates

NCT00588250

COMPLETED NA

Acupuncture for Non-cyclical Breast Pain

NCT00275574

COMPLETED Phase 3

Vertebroplasty for the Treatment of Fractures Due to Osteoporosis

NCT00068822

COMPLETED NA

Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?

NCT00434915

COMPLETED

Characterization of Skeletal Muscle Using Magnetic Resonance Elastography (MRE)

NCT00588432

COMPLETED Phase 1

BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.

NCT00252200

COMPLETED NA

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

NCT00166348

COMPLETED Phase 3

Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure

NCT00170183

COMPLETED Phase 2

Exisulind Versus Placebo After Surgical Removal of the Prostate

NCT00166426

COMPLETED Phase 1

Minocycline in Primary Sclerosing Cholangitis (PSC)

NCT00630942

COMPLETED Phase 2

Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain

NCT00275600

COMPLETED Phase 2

Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast Cancer

NCT01215162

COMPLETED Phase 2

Betaine in Patients With Nonalcoholic Steatohepatitis

NCT00586911

COMPLETED

Ultrasound-based Intima-Media Thickness Measurements

NCT00588484

COMPLETED Phase 2

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma

NCT00635154

COMPLETED Phase 1

CellCept in p-ANCA Vasculitis

NCT00405860

COMPLETED

Methylene Blue Chromoendoscopy in Barrett's Esophagus

NCT00587652

COMPLETED Phase 2

Biomarkers in Phototherapy of Barrett's Esophagus

NCT00587600

COMPLETED Phase 2

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

NCT00005989

COMPLETED

Repeatability of X-Ray, MRI, and Gait Analysis

NCT00581841

TERMINATED NA

Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention

NCT00588471

COMPLETED

Coronary Disease Morbidity and Mortality in a Population

NCT00005502

COMPLETED NA

Aerobic Exercise Intervention for Knee Osteoarthritis

NCT00049816

COMPLETED

MMF Influence on HCV Viral Evolution After Liver Transplantation

NCT00170131

TERMINATED Phase 1

BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling

NCT00252213

COMPLETED NA

DHEA Replacement in Adrenalectomized/Hypoadrenal Patients

NCT00279929

COMPLETED Phase 4

Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes

NCT00276393

COMPLETED Phase 2

Exisulind Prior to Radical Prostatectomy

NCT00166478

COMPLETED

Genomics of Primary Sclerosing Cholangitis (PSC)

NCT01161992

COMPLETED Phase 1

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

NCT00653757

COMPLETED

Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)

NCT01161953

COMPLETED Phase 3

The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.

NCT00275665

← Previous Page 56 of 57 Next →

Phase Distribution

PhaseTrial count
Phase 1 435
Phase 2 386
Phase 3 86
Phase 4 166

What is open in the Mayo Clinic pipeline

544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).

Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).

Top condition: Healthy (36 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.